To print: Select File and then Print from your browser's menu --------------------------------------------------------------------------------------- Title: Low-Dose, Drospirenone-Containing Oral Contraceptive Approved in Europe URL: http://www.pslgroup.com/dg/220BC6.htm Doctor's Guide May 7, 2008
NEW YORK -- May 7, 2008 -- An oral contraceptive containing the unique progestin drospirenone combined with a low dose of ethinyl estradiol has been approved in the European Union and is expected to be available by autumn 2008. The contraceptive, marketed as Yaz, is available in a new dosing regimen of 24 days of active hormone tablets and 4 days of placebo. The drospirenone/ethinyl estradiol contraceptive has been available in the United States since 2006, where it is the only oral contraceptive approved for 3 indications: contraception as well as for the treatment of moderate acne and the emotional and physical symptoms associated with premenstrual dysphoric disorder (PMDD), such as mood swings, irritability, anxiety, food cravings, breast tenderness, bloating, and headache. Bayer Schering Pharma, the makers of the contraceptive, plan to submit for expanded approval in the European Union for both the acne and PMDD indications. SOURCE: Bayer Schering Pharma --------------------------------------------------------------------------------------------- Copyright © 1999 P\S\L Consulting Group Inc. All rights reserved. Republication or redistribution of P\S\L content is expressly prohibited without the prior written consent of P\S\L. P\S\L shall not be liable for any errors, omissions or delays in this content or any other content on its sites, newsletters or other publications, nor for any decisions or actions taken in reliance on such content. --------------------------------------------------------------------------------------------- This news story was printed from *Doctor's Guide to the Internet* located at http://www.docguide.com --------------------------------------------------------------------------------------- Return to News Story Page This site is maintained by webmaster@pslgroup.com Please contact us with any comments, problems or bugs. All contents Copyright (c) 1998 P\S\L Consulting Group Inc. All rights reserved.